Skip to main content
. 2016 Mar 9;7(15):20704–20717. doi: 10.18632/oncotarget.8007

Figure 2. EPB41L4A-AS2 expression in different solid tumors in TCGA.

Figure 2

EPB41L4A-AS2 expression: (A) in breast cancer tissues (N = 837) and normal tissues (N = 105), (B) in breast cancer with ER positive (N = 584) or negative (N = 174), (C) in breast cancer with PR positive (N = 508) or negative (N = 247), (D) in breast cancer with HER-2 positive (N = 113) or negative (N = 630), (E) in renal cancer tissues (N = 448) and normal tissues (N = 47), (F) in lung cancer tissues (N = 478) and normal tissues (N = 58). ***p < 0. 001; *p < 0.05.